Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.
ClinicalTrials.gov study NCT04647110. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in
ClinicalTrials.gov study NCT02927262. IPD Sharing: YES. Countries: 21. Publications: 0.
A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)
ClinicalTrials.gov study NCT02532868. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)
ClinicalTrials.gov study NCT03109301. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
ClinicalTrials.gov study NCT05294731. IPD Sharing: YES. Countries: 1. Publications: 0.
Identification of Novel Targetable Kinases in SR-a GvHD
ClinicalTrials.gov study NCT04342442. IPD Sharing: NO. Countries: 0. Publications: 4.
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome
ClinicalTrials.gov study NCT04496960. IPD Sharing: YES. Countries: 1. Publications: 0.
Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns
ClinicalTrials.gov study NCT04351334. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Janus Kinase_3 in Juvenile Onset Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT04293510. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
ClinicalTrials.gov study NCT01291017. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Pro
ClinicalTrials.gov study NCT03321630. IPD Sharing: NO. Countries: 1. Publications: 0.
Serum TAM Receptor Tyrosine Kinase Ligands in Acute Pancreatitis
ClinicalTrials.gov study NCT07023055. IPD Sharing: NO. Countries: 1. Publications: 0.
A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
ClinicalTrials.gov study NCT01588678. IPD Sharing: YES. Countries: 1. Publications: 0.
De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT01697163. IPD Sharing: Not stated. Countries: 0. Publications: 1.
CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)
ClinicalTrials.gov study NCT04182763. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy
ClinicalTrials.gov study NCT02516813. IPD Sharing: NO. Countries: 8. Publications: 0.
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
ClinicalTrials.gov study NCT03572634. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
ClinicalTrials.gov study NCT02439138. IPD Sharing: NO. Countries: 1. Publications: 0.
Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis
ClinicalTrials.gov study NCT00670202. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)
ClinicalTrials.gov study NCT04458051. IPD Sharing: YES. Countries: 42. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.